Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01447849 · ClinicalTrials.gov registry record · Phase 2
Lubiprostone and Mucus Secretion in Patients With Chronic Constipation
A Phase 2 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01447849 is a Phase 2 study that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 40 participants.
The verdict
NCT01447849, a Phase 2 study, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators hypothesize that the symptoms of chronic constipation in some patients are developed due to diminished production and secretion of the alimentary tract mucus resulting in poor lubrication. Therefore, the investigators assume that administration of lubiprostone may restore this lubrication impairment by stimulation of mucus production and secretion within the gastrointestinal tract.
Interventions
- DRUG placebo
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01447849
The ClinicalTrials.gov registry entry for NCT01447849 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01447849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01447849 about?
NCT01447849 is a clinical study titled "Lubiprostone and Mucus Secretion in Patients With Chronic Constipation". The investigators hypothesize that the symptoms of chronic constipation in some patients are developed due to diminished production and secretion of the alimentary tract mucus resulting in poor lubrication. Therefore, the investigators assume that administration of lubiprostone may restore this lub...
What is the current status of trial NCT01447849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2011-08. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01447849?
The interventions under investigation include: placebo (DRUG), lubiprostone (DRUG).
Who is sponsoring clinical trial NCT01447849?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.